Mission Pharmacal Company Profile
✉ Email this page to a colleague
What is the competitive landscape for MISSION PHARMACAL
MISSION PHARMACAL has four approved drugs.
There is one US patent protecting MISSION PHARMACAL drugs.
Drugs and US Patents for Mission Pharmacal
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mission Pharmacal | CARBINOXAMINE MALEATE | carbinoxamine maleate | TABLET;ORAL | 090756-001 | May 27, 2011 | RX | No | Yes | ⤷ Start Trial | ⤷ Start Trial | |||||
| Mission Pharmacal | POTASSIUM IODIDE | potassium iodide | SOLUTION;ORAL | 206211-001 | Mar 24, 2016 | OTC | No | Yes | ⤷ Start Trial | ⤷ Start Trial | |||||
| Mission Pharmacal | THIOLA EC | tiopronin | TABLET, DELAYED RELEASE;ORAL | 211843-001 | Jun 28, 2019 | AB | RX | Yes | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.

